228 related articles for article (PubMed ID: 7679817)
41. Comparative efficacy of immunosuppressive drugs in xenografting.
Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
[No Abstract] [Full Text] [Related]
42. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
[No Abstract] [Full Text] [Related]
43. Effect of lipoprostaglandin E1 in concordant xenografts.
Yoshida Y; Kitamura S; Kawachi K; Kawata T; Sakaguchi H; Gojo S
Transplant Proc; 1996 Jun; 28(3):1410-1. PubMed ID: 8658716
[No Abstract] [Full Text] [Related]
44. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
[No Abstract] [Full Text] [Related]
45. Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival.
Nardo B; Valdivia LA; Pan F; Celli S; Tsugita M; Demetris AJ; Fung JJ; Starzl TE
Transplant Proc; 1994 Jun; 26(3):1208. PubMed ID: 7518112
[No Abstract] [Full Text] [Related]
46. Long-term survival of heart and liver xenografts with splenectomy and FK 506.
Celli S; Valdivia LA; Fung JJ; Demetris AJ; Marino IR; Murase N; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):647-8. PubMed ID: 7679830
[TBL] [Abstract][Full Text] [Related]
47. Prolongation of concordant xenograft survival by treatment with FTY720.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
[No Abstract] [Full Text] [Related]
48. Simple therapy for cardiac concordant xenotransplantation: only 1 week of DSG administration with suppression of t-cell reactions.
Kubota S; Miyatake T; Miyazaki K; Watanabe T; Mafune N; Watanabe S; Abe K; Murashita T; Yasuda K
Transplant Proc; 2000 Aug; 32(5):1020. PubMed ID: 10936329
[No Abstract] [Full Text] [Related]
49. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
[No Abstract] [Full Text] [Related]
50. Nerve xenograft transplantation. Immunosuppression with FK-506 and RS-61443.
Hebebrand D; Zohman G; Jones NF
J Hand Surg Br; 1997 Jun; 22(3):304-7. PubMed ID: 9222906
[TBL] [Abstract][Full Text] [Related]
51. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
Hasan RI; Sriwatanawongsa V; Wallwork J; White DJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):421-2. PubMed ID: 8438362
[No Abstract] [Full Text] [Related]
52. Rejection and accommodation in the hamster-to-rat heart transplantation model.
Bouwman E; Scheringa M; Nio D; IJzermans JN; Marquet RL
Transplant Proc; 1994 Apr; 26(2):992-3. PubMed ID: 8171723
[No Abstract] [Full Text] [Related]
53. Immunopharmacology of new xenobiotic immunosuppressive molecules.
Morris RE
Semin Nephrol; 1992 Jul; 12(4):304-14. PubMed ID: 1384096
[No Abstract] [Full Text] [Related]
54. Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.
Valdivia LA; Fung JJ; Demetris AJ; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3269-71. PubMed ID: 1721432
[No Abstract] [Full Text] [Related]
55. Effects of 15-deoxyspergualin and FK506 on the histology and survival of hamster-to-rat cardiac xenotransplantation.
Nakajima K; Sakamoto K; Ochiai T; Asano T; Isono K
Transplant Proc; 1989 Feb; 21(1 Pt 1):546-8. PubMed ID: 2468223
[No Abstract] [Full Text] [Related]
56. The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
Pruitt SK; Halperin EC; Bollinger RR
Transplant Proc; 1991 Feb; 23(1 Pt 1):585-6. PubMed ID: 1990618
[No Abstract] [Full Text] [Related]
57. Cardiac xenotransplantation into complement 5-deficient mice.
Sakakibara N; Wolf P; Kriett J; Kapelanski DP; Jamieson SW
Transplant Proc; 1996 Apr; 28(2):689-90. PubMed ID: 8623347
[No Abstract] [Full Text] [Related]
58. Timing of spleen activation in rats treated with cyclophosphamide (CyP): its role in a hamster-to-rat heterotopic heart xenotransplantation (HHX) model.
Catena M; Lattanzio G; Maggiano N; Musiani P; Ferla G
Transplant Proc; 1994 Jun; 26(3):1182-3. PubMed ID: 8029878
[No Abstract] [Full Text] [Related]
59. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
Steinbrüchel DA; Lillevang ST; Nielsen B; Kemp E
Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
[No Abstract] [Full Text] [Related]
60. Hamster-to-rat liver xenografts protect extrahepatic organs from rejection.
Valdivia LA; Demetris AJ; Fung JJ; Celli S; Frye C; Murase N; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):414-5. PubMed ID: 7679816
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
